Avai Bio (AVAI) Cost of Revenue (2020 - 2022)
Avai Bio's Cost of Revenue history spans 2 years, with the latest figure at $213912.0 for Q4 2022.
- For Q4 2022, Cost of Revenue changed N/A year-over-year to $213912.0; the TTM value through Mar 2023 reached $817754.0, changed N/A, while the annual FY2025 figure was $85164.0, 182.53% up from the prior year.
- Cost of Revenue for Q4 2022 was $213912.0 at Avai Bio, up from $102866.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $500976.0 in Q4 2020 and bottomed at $102866.0 in Q2 2022.